Appointment booking for Dr. Mary Uckerman, MD is currently not available.Dr. Mary Uckerman, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Mary Uckerman, MD (she/her) is a Pathologist in Melrose Park, IL with over 18 years of experience. What is your opinion of Dr. Mary Uckerman, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mary Uckerman, MD has received over $1,010 which includes payments from the following companies:
$201.32 from Celgene Corporation
$193.14 from TESARO, Inc.
$150.95 from Ipsen Biopharmaceuticals, Inc
$74.69 from Genentech USA, Inc.
$72.62 from Janssen Biotech, Inc.
$45.37 from E.R. Squibb & Sons, L.L.C.
$37.09 from Merck Sharp & Dohme Corporation
$33.71 from Bayer HealthCare Pharmaceuticals Inc.
$31.76 from Prometheus Laboratories Inc.
$28.11 from Incyte Corporation
$22.88 from Astellas Pharma US Inc
$20.52 from Rigel Pharmaceuticals, Inc.
$18.89 from Taiho Oncology, Inc.
$18.00 from Eisai Inc.
$17.62 from Blue Earth Diagnostics Limited
$16.18 from Takeda Pharmaceuticals U.S.A., Inc.
$15.55 from Boehringer Ingelheim Pharmaceuticals, Inc.
$12.45 from Pfizer Inc.
Payments received by Dr. Mary Uckerman, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!